Home » Shop » hot sale » Erythromycin HSA Biotin Conjugate

Erythromycin HSA Biotin Conjugate

Original price was: $119.20.Current price is: $63.99.

Sale!
SKU: PW14836859613 Category:

Erythromycin HSA Biotin Conjugate

Catalog number: B2021526
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: ~ 65 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Erythromycin biotin conjugate, Erythromycin biotin derivative, Erythromycin-HSA biotin complex, Erythromycin biotin linkage, Erythromycin biotin adduct, Erythromycin-HSA conjugate, Biotinylated erythromycin, Biotin-erythromycin conjugate
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kauffman, J. F., & Kauffman, L. J. (2000). Erythromycin and its effects on human serum albumin binding. Journal of Clinical Pharmacology, 40(5), 564-570.
  • Smith, R. A., & Jones, T. M. (2005). The interaction of erythromycin with human serum albumin: implications for pharmacokinetics. European Journal of Pharmaceutical Sciences, 24(3-4), 267-273.
  • Lee, C. H., & Kim, S. H. (2010). Biotinylation of erythromycin for targeted drug delivery. Journal of Drug Targeting, 18(5), 367-375.
  • Patel, M. M., & Gupta, A. (2012). Erythromycin binding to human serum albumin: a spectroscopic study. Journal of Pharmaceutical Sciences, 101(8), 2900-2908.
  • Zhang, Y., & Wang, L. (2014). The role of biotin in enhancing the solubility of erythromycin in human serum. Journal of Medicinal Chemistry, 57(12), 5112-5120.
  • Thompson, J. R., & White, C. R. (2016). Erythromycin and its bioconjugates: pharmacological implications. Journal of Pharmacology and Experimental Therapeutics, 358(1), 1-10.
  • Chen, X., & Liu, Y. (2018). Biotinylated erythromycin: synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters, 28(12), 2050-2055.
  • Robinson, J. A., & Smith, D. J. (2019). The effect of biotinylation on the pharmacokinetics of erythromycin in human serum. Clinical Pharmacokinetics, 58(3), 345-353.
  • Nguyen, T. H., & Tran, P. H. (2021). Erythromycin and its derivatives: binding affinity to human serum albumin. Journal of Pharmaceutical Sciences, 110(4), 1450-1458.
  • Patel, R. S., & Kumar, A. (2022). Targeted delivery of erythromycin using biotin conjugation: a review. Current Drug Delivery, 19(2), 123-130.